Cat.#: ACPP-1287
| Despition | Dopamine Receptor D1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1592 | Human CRYAB Protein (AC1592) | 20 µg | inquiry |
| ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg | inquiry |
| ACPP-1313 | Norepinephrine Transporter Blocking Peptide (AC1313) | 250 µg | inquiry |
| ACPP-1470 | Human CLTA Protein (AC1470) | 5 µg | inquiry |
| ACPP-1332 | GAD65 Blocking Peptide (AC1332) | 250 µg | inquiry |
| ACPP-1602 | Human AKR7A2 Protein (AC1602) | 5 µg | inquiry |
| ACPP-1514 | Human Thyroid Stimulating Hormone Receptor (Active) (A105346) (AC1514) | 2 µg | inquiry |
| ACPP-1226 | PDE7A Blocking Peptide (AC1226) | 250 µg | inquiry |
| ACPP-1553 | Human NRG4 Protein (AC1553) | 2 µg | inquiry |
| ACPP-1361 | PAX2 Blocking Peptide (AC1361) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.